Inflammatory Bowel Disease in Patients with Chronic Abdominal Pain: A Colonoscopy-Based Cross-Sectional Study
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.235 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Shrusti Joshi und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Chronic abdominal pain is a common and non-specific complaint that may be the first sign of inflammatory bowel disease (IBD), yet it overlaps heavily with functional and infectious disorders. We examined how often IBD underlies chronic abdominal pain in patients referred for colonoscopy, and characterised the features that separate ulcerative colitis (UC) from Crohn's disease (CD).
Methods
In this cross-sectional observational study, 50 adults with chronic abdominal pain (> 3 months) undergoing colonoscopy at a tertiary teaching hospital in Jaipur were evaluated. Diagnosis rested on colonoscopy with targeted biopsy, supported by serology (pANCA, ASCA) and faecal calprotectin. Disease was classified by the Montreal system and graded by Truelove–Witts/Mayo and CDAI scores. Groups were compared with the chi-square or Fisher exact test (p < 0.05 significant).
Results
Ulcerative colitis accounted for 42 patients (84.0%) and Crohn's disease for 8 (16.0%). The cohort was young (mean age 36.6 ± 11.5 years) and predominantly female (70.0%), with no demographic difference between subtypes. Rectal bleeding, mucus discharge and tenesmus were significantly commoner in UC, while weight loss and perianal disease characterised CD. CD presented later (15.6 vs 8.2 months; p = 0.006) and carried higher ESR, CRP and calprotectin and lower albumin. Colonoscopy and histology separated the subtypes cleanly, and pANCA (UC) and ASCA (CD) reached predictive values approaching 97% in combination. Complications were commoner in CD (75.0% vs 38.1%; p = 0.046).
Conclusion
IBD was a frequent diagnosis in patients with chronic abdominal pain, with UC predominating but CD behaving more aggressively and presenting later. Colonoscopy with biopsy was the cornerstone of diagnosis, with serology and calprotectin as useful non-invasive adjuncts.
Zitieren
APA
Joshi, S., Vyas, N., Rao, R. S., & Sharma, S. (2026). Inflammatory Bowel Disease in Patients with Chronic Abdominal Pain: A Colonoscopy-Based Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.235
Vancouver
Joshi S, Vyas N, Rao RS, Sharma S. Inflammatory Bowel Disease in Patients with Chronic Abdominal Pain: A Colonoscopy-Based Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.235
BibTeX
@article{Joshi2026,
author = {Joshi, Shrusti and Vyas, N.L. and Rao, Randhir Singh and Sharma, Shaffi},
title = {Inflammatory Bowel Disease in Patients with Chronic Abdominal Pain: A Colonoscopy-Based Cross-Sectional Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.235}
}
EUVIMED